Hoste的临床试验
总计845个结果
-
Therakos, Inc., a Mallinckrodt Company终止
-
Dana-Farber Cancer Institute招聘中
-
Hospital Authority, Hong KongNovartis Pharmaceuticals; The Hong Kong Blood Cancer Foundation未知
-
National Institute of Arthritis and Musculoskeletal...终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)终止
-
Shanghai General Hospital, Shanghai Jiao Tong University...未知
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Washington University School of MedicineCellect Biotechnology终止
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)完全的
-
National Institute of Nursing Research (NINR)Fred Hutchinson Cancer Center终止
-
Oncoimmune, Inc., a subsidiary of Merck & Co.,...National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio State University 和其他合作者完全的Efprezimod Alfa (CD24Fc, MK-7110) 用于预防清髓性同种异体造血干细胞移植 (HSCT) 后急性移植物抗宿主病 (GVHD) 的 II 期试验 (MK-7110-002)白血病 | 造血干细胞移植 | 移植物抗宿主病美国
-
Children's Hospital Medical Center, Cincinnati终止
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Maryland Stem Cell Research Fund终止
-
Washington University School of MedicineIncyte Corporation招聘中
-
Hospital Universitario Dr. Jose E. Gonzalez招聘中
-
Fundación Oftalmológica de Santander Clínica Carlos...Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud - IDCBIS尚未招聘移植物抗宿主病
-
ViGenCell Inc.尚未招聘
-
Zhejiang University招聘中
-
Centro de Hematología y Medicina Interna邀请报名
-
Nantes University Hospital终止
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)终止
-
University of Michigan Rogel Cancer CenterAmgen; Mallinckrodt完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey终止
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的